No Data
No Data
No Data
No Data
No Data
Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation
Yahoo Finance12:42 ET
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals Among Healthcare Movers
Seeking AlphaApr 24 10:00 ET
Express News | Capricor Therapeutics Inc: Granted Subsequent Type-B Clinical Meeting With FDA in Q2 to Continue to Discuss Pathway to Bla
Moomoo 24/7Apr 24 09:05 ET
Express News | Capricor Therapeutics: FDA Feedback Supports Requests for Pre-Bla Meeting,Subsequent Rolling Bla Submission Following Upcoming Q2 Type-B FDA Meeting
Moomoo 24/7Apr 24 09:04 ET
Express News | Capricor Therapeutics: Aligned With FDA on Demonstration of Non-Clinical Comparability; Allowing for Immediate Use of San Diego Manufacturing Facility
Moomoo 24/7Apr 24 09:04 ET
Express News | Capricor Therapeutics Announces Type-B Meeting With FDA For CAP-1002 Program For Duchenne Muscular Dystrophy, FDA Feedback Supports Requests For Pre-BLA Meeting And Subsequent Rolling BLA Submission Following Upcoming Q2 Type-B FDA Meeting
Moomoo 24/7Apr 24 09:04 ET
No Data
No Data
TrytosaveabitOP : Capricor Therapeutics Inc: Granted Subsequent Type-B Clinical Meeting With FDA in Q2 to Continue to Discuss Pathway to Bla